Washington-ALsharqiya January 24: White House adviser and chief epidemiologist in the United States, Anthony Fauchi, said that the vaccine that Johnson & Johnson is developing will be approved within a period not exceeding two weeks. The Johnson & Johnson vaccine is distinguished from the Pfizer and Moderna vaccines in that it consists of a single dose, while the other vaccines require two doses with an interval of up to six weeks. Johnson & Johnson expects to release 100 million doses of its vaccine by next April.
- Home
-
News
-
News in pictures
-
Latest News
-
Category
-
-
AlSharqiya Programs
-
Latest AlSharqiya Programs
-
AlSharqiya Programs
-
AlSharqiya Programs
-
-
AlSharqiya News Programs
-
Latest Programs
-
AlSharqiya News Programs
-
AlSharqiya News Programs
MANCHET AHMAR
Hosted By : Dina Alqsos
-
-
Live
-
Al Shaqriya Live
-
Al Sharqiya News Live
-
- Tv Schedule